Our Technology
Home/Products/Immunofluorescence-Platform/COVID-19/Finecare™ 2019-nCoV RBD Test
Finecare™ 2019-nCoV RBD Test
RBD (receptor binding domain) of 2019-nCoV virus S1 protein is the region that binds to the ACE2 receptor on human cells as the first step of virus invading.
  • Performance Evaluation
    The Finecare™ 2019-nCoV RBD Antibody Test is a fluorescence immunoassay used along with Finecare™ FIA Meters for qualitative and semi-quantitative detection of spike receptor-binding domain (RBD) antibodies of novel coronaviruses (2019-nCoV) in human fingerstick whole blood, venipuncture whole blood, serum or plasma specimen.

    The 2019-nCoV RBD antibodies are protective antibody produced by the human body after inoculation with 2019-nCoV vaccine or infection with 2019-nCoV. The test is intended as an aid to assess the adaptive humoral immune response to the 2019-nCoV RBD protein.
    1. Store at 4~30°C in the sealed pouch up to the expiration date printed on the package. Do not freeze.
    2. The test device should be used within 1 hour after taking out from the foil envelope.
    3. Keep away from sunlight, moisture and heat.
    4. Kit contents are stable until the expiration date printed on the outer box.
Cat. No. Sample Type Sample Volume Reaction Time Storage Temperature Shelf Life Qualification
W278 Fingerstick whole blood
venipuncture whole blood
serum or plasma
20μL 15 mins 4-30℃ 24 months CE

Get Free Quote Now
If you’re interested in our products or service, please leave your information here, and we will be in touch with you shortly.
Wondfo is committed to quality customer service. If you have any question, please feel free to contact us.
This website uses cookies. By continuing to browse or by clicking “Accept”, you agree to our use of cookies to enhance your experience.

Choose your location

It looks like you are located in: Spain
You are trying to view a page from a different country or region. *Not all products and services may be available in your country or region.